Added Value of Contrast‐Enhanced T1‐Weighted and Diffusion‐Weighted Sequences for Characterization of Incidental Findings on Whole Body Magnetic Resonance Imaging in Plasma‐Cell Disorders

[1]  H. Goldschmidt,et al.  Diffusion‐weighted imaging for non‐invasive and quantitative monitoring of bone marrow infiltration in patients with monoclonal plasma cell disease: a comparative study with histology , 2011, British journal of haematology.

[2]  M. Galia,et al.  Whole-body MRI in patients with lymphoma: collateral findings , 2016, La radiologia medica.

[3]  Hans Erik Johnsen,et al.  International Myeloma Working Group updated criteria for the diagnosis of multiple myeloma. , 2014, The Lancet. Oncology.

[4]  H. Völzke,et al.  Potentially relevant incidental findings on research whole-body MRI in the general adult population: frequencies and management , 2013, European Radiology.

[5]  C. Messiou,et al.  Frequency, distribution and clinical management of incidental findings and extramedullary plasmacytomas in whole body diffusion weighted magnetic resonance imaging in patients with multiple myeloma , 2016, Haematologica.

[6]  G. Morgan,et al.  Whole-body diffusion-weighted MR imaging for assessment of treatment response in myeloma. , 2014, Radiology.

[7]  J. Jaremko,et al.  Whole-body MRI in neurofibromatosis: incidental findings and prevalence of scoliosis , 2012, Skeletal Radiology.

[8]  K. Verstraete,et al.  Value of whole body MRI and dynamic contrast enhanced MRI in the diagnosis, follow-up and evaluation of disease activity and extent in multiple myeloma. , 2013, European journal of radiology.

[9]  Vicky Goh,et al.  Guidelines for the use of imaging in the management of patients with myeloma , 2017, British journal of haematology.